(COP) CompuGroup Medical SE & Co. - Ratings and Ratios

CompuGroup Medical SE & Co. KGaA is a leading global provider of e-health services, operating across multiple regions including Germany, Western and Eastern Europe, North America, and other international markets. The companys diversified portfolio is structured around three primary business segments: Ambulatory Information Systems (AIS), Hospital Information Systems (HIS), and Pharmacy Information Systems (PCS), each catering to different aspects of the healthcare sector.

The AIS segment is focused on delivering comprehensive management software solutions for healthcare providers, including registered physicians, medical care centers, and physician networks. These solutions encompass a wide range of functionalities such as clinical, administrative, and billing processes, alongside internet and intranet platforms for secure information exchange between healthcare professionals and patients. Additionally, the segment offers data-driven products, software interfaces, medical decision support tools, and digital applications tailored for various stakeholders in the healthcare ecosystem.

The HIS segment serves the inpatient healthcare sector by providing clinical and administrative solutions designed for acute care hospitals, rehabilitation centers, and other healthcare institutions. These solutions facilitate patient administration, resource management, medical documentation, billing, and financial controlling, as well as clinical applications supporting specialist departments and medical laboratories.

The PCS segment is dedicated to pharmacies, offering software applications that support administrative and billing-related processes. These solutions aim to streamline the supply chain for medication, from procurement and inventory management to retail activities, thereby enhancing operational efficiency for pharmacies.

With a history dating back to 1987 and headquartered in Koblenz, Germany, CompuGroup Medical has established itself as a significant player in the health care technology sector. The companys commitment to innovation is reflected in its diverse product portfolio and its presence across various international markets.

Analyzing the provided and , we observe that CompuGroup Medical SE & Co. KGaA (COP) is currently trading at €22.08, with its 20-day and 50-day simple moving averages (SMA) indicating a stable short-term trend. The stock has shown a significant increase from its 52-week low of €13.23, and is currently near its 52-week high of €25.30. The Average True Range (ATR) of 0.09 suggests low volatility. From a fundamental perspective, the company has a market capitalization of €1140.23M and a P/E ratio of 42.38, indicating a relatively high valuation compared to its earnings.

Forecasting the future performance of COP involves analyzing both its technical and fundamental data. Given the stocks current price is near its SMA20 and SMA50, and significantly above its SMA200, it indicates a positive long-term trend. The low ATR suggests that the stock is experiencing a period of consolidation. With a P/E ratio of 42.38, investors are pricing in high growth expectations. If CompuGroup Medical continues to innovate and expand its market share, it could potentially see its stock price rise towards its 52-week high. However, if the company fails to meet these growth expectations, the stock could face a correction. Based on the current data, a potential short-term target could be €25.00, aligning with its 52-week high, while a stop-loss could be set around €21.00 to mitigate potential downside risks.